Keybanc analyst Sean Eastman maintains AECOM (NYSE:ACM) with a Overweight and raises the price target from $91 to $100.
Pharma Industry on Alert as Biden Administration Explores Patent Seizure Powers
The White House is endorsing a contentious power that permits the government to reclaim patents for specific